Shigella vector for delivering DNA to a mammalian cell
US5824538A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Sep 6, 1995 |
| Grant date | Oct 20, 1998 |
| Priority date | — |
| Expiry date | Sep 6, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/822
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
We describe a bacterial delivery system for the delivery of DNA and antigens into cells. We constructed an attenuated bacterial vector which enters mammalian cells and ruptures delivering functional plasmid DNA, such as a mammalian expression plasmid, and antigens into the cell cytoplasm. This Shigella vector was designed to deliver DNA to colonic surfaces, thus opening the possibility of oral and other mucosal DNA immunization and gene therapy strategies. The attenuated Shigella is also useful as a vaccine for reducing disease symptoms caused by Shigella.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.